<DOC>
	<DOCNO>NCT02026297</DOCNO>
	<brief_summary>The aim study characterize coagulation change , use thromboelastography ( TEG ) , prophylactic tranexamic administration cesarean delivery . Specifically , TEG value compare patient receive prophylactic tranexamic acid placebo surgery , elective cesarean delivery , 2 hour postpartum . Postpartum hemorrhage ( PPH ) increase incidence United States , renew interest multimodal approach blood conservation cesarean delivery . Pharmacologic therapy antifibrinolytic agent , tranexamic acid ( TA ) , show reduce estimate blood loss ( EBL ) cesarean delivery , effect global coagulation assess TEG , correlate lower blood loss , elucidate . This study conduct randomize , double-blind , control trial two study arm : control ( 60 patient ) ; treatment ( 60 patient ) . Subjects pre-medicated routine pre-cesarean delivery medication include oral sodium citrate 30 mL intravenous ( IV ) metoclopramide 10 mg. A peripheral IV noninvasive hemoglobin monitor place , baseline lab sent : type screen , serum hemoglobin , platelet count , fibrinogen , activate partial thromboplastin time ( aPTT ) , prothrombin time ( PT ) , baseline TEG value ( r time , k time , alpha angle , maximum amplitude ) . Patients blood pressure , heart rate , pulse oximetry measure throughout surgery per standard care . Patients receive IV lactate Ringers ' ( LR ) solution prior surgery throughout surgery , volume record goal le 2 L unless IV fluid clinically indicate . All patient spinal anesthetic per standard care , hyperbaric bupivacaine 12 mg , fentanyl 10 μg , hydromorphone 100 μg . If anesthetic plan alter ( combine spinal-epidural , general anesthesia conversion , general anesthesia plan ) , indication medication dos use noted analysis . Immediately follow induction anesthesia prior skin incision , infusion study solution initiate . Study solution consist : 1 . Control group : 100 mL 0.9 % normal saline ( NS ) . 2 . Treatment group : 100 mL 0.9 % NS contain 1g tranexamic acid ( TA ) . Study solution infuse via infusion pump 10 minute . Blood loss measure visual estimate weight surgical sponge . Noninvasive hemoglobin measure throughout study . All routine care lab value note . At minimum , one lab panel send one hour study solution initiation ( hemoglobin , fibrinogen , platelet count , aPTT , PT , TEG ) .</brief_summary>
	<brief_title>Tranexamic Acid Thromboelastography During Cesarean Delivery</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>American Society Anesthesiologists ( ASA ) class I II age 1850 year singleton vertex pregnancy schedule elective cesarean delivery ( without prior labor ) plan pfannensteil incision allergy tranexamic acid history inherit acquire thrombophilia history deep vein thrombosis pulmonary embolism , use anticoagulant medication . preeclampsia , hemolysis , elevate liver enzyme , low platelet syndrome seizure disorder</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>postpartum hemorrhage</keyword>
	<keyword>estimate blood loss</keyword>
	<keyword>coagulation</keyword>
	<keyword>thromboelastography</keyword>
	<keyword>tranexamic acid</keyword>
</DOC>